                         SEQUENCE LISTING

<110>  Forida State University Research Foundation, Inc.
 
<120>  MODIFIED FRAGMENTS FROM THE OCTAREPEAT REGION OF PRION PROTEIN AS
        HEMIN BINDERS

<130>  232109-01510

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  252
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Asn Leu Gly Cys Trp Met Leu Val Leu Phe Val Ala Thr Trp 
1               5                   10                  15      


Ser Asp Leu Gly Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Trp Asn 
            20                  25                  30          


Thr Gly Gly Ser Arg Tyr Pro Gly Gln Gly Ser Pro Gly Gly Asn Arg 
        35                  40                  45              


Tyr Pro Pro Gln Gly Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly 
    50                  55                  60                  


Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly 
65                  70                  75                  80  


Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln Gly Gly Thr His Ser 
                85                  90                  95      


Gln Trp Asn Lys Pro Ser Lys Pro Lys Thr Asn Met Lys His Met Ala 
            100                 105                 110         


Gly Ala Ala Ala Ala Gly Ala Val Val Gly Gly Leu Gly Gly Tyr Met 
        115                 120                 125             


Leu Gly Ser Ala Met Ser Arg Pro Ile Ile His Phe Gly Ser Asp Tyr 
    130                 135                 140                 


Glu Asp Arg Tyr Tyr Arg Glu Asn Met His Arg Tyr Pro Asn Gln Val 
145                 150                 155                 160 


Tyr Tyr Arg Pro Met Asp Glu Tyr Ser Asn Gln Asn Asn Phe Val His 
                165                 170                 175     


Asp Cys Val Asn Ile Thr Ile Lys Gln His Thr Val Thr Thr Thr Thr 
            180                 185                 190         


Lys Gly Glu Asn Phe Thr Glu Thr Asp Val Lys Met Met Glu Arg Val 
        195                 200                 205             


Val Glu Gln Met Cys Ile Thr Gln Tyr Glu Arg Glu Ser Gln Ala Tyr 
    210                 215                 220                 


Tyr Gln Arg Gly Ser Ser Met Val Leu Phe Ser Ser Pro Pro Val Ile 
225                 230                 235                 240 


Leu Leu Ile Ser Phe Leu Ile Phe Leu Ile Val Gly 
                245                 250         


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE

<400>  2

Pro His Gly Gly Gly Trp Gly Gln 
1               5               


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE

<400>  3

Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


<210>  4
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE

<400>  4

Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


Pro His Gly Gly Gly Trp Gly Gln 
            20                  


<210>  5
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE

<400>  5

Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp Gly Gln 
            20                  25                  30          


<210>  6
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE

<400>  6

Gly Gln Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp 
1               5                   10                  15      


Gly Gln Pro His Gly Gly Gly Trp Gly Gln Pro His Gly Gly Gly Trp 
            20                  25                  30          


Gly Gln Gly Gly Gly 
        35          


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  X = 2-AMINOISOBUTYRIC ACID

<400>  7

Xaa His Gly Gly Gly Trp Gly Gln 
1               5               


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  X = 2-AMINOISOBUTYRIC ACID

<400>  8

Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


<210>  9
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE


<220>
<221>  MISC_FEATURE
<222>  (1)..(24)
<223>  X = 2-AMINOISOBUTYRIC ACID

<400>  9

Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


Xaa His Gly Gly Gly Trp Gly Gln 
            20                  


<210>  10
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GENERATED PEPTIDE


<220>
<221>  MISC_FEATURE
<222>  (1)..(32)
<223>  X = 2-AMINOISOBUTYRIC ACID

<400>  10

Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp Gly Gln 
1               5                   10                  15      


Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp Gly Gln 
            20                  25                  30          


<210>  11
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETICALLY GERATED PEPTIDE


<220>
<221>  MISC_FEATURE
<222>  (1)..(37)
<223>  X = 2-AMINOISOBUTYRIC ACID

<400>  11

Gly Gln Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp 
1               5                   10                  15      


Gly Gln Xaa His Gly Gly Gly Trp Gly Gln Xaa His Gly Gly Gly Trp 
            20                  25                  30          


Gly Gln Gly Gly Gly 
        35          


